Philadelphia, PA

Cabaletta Bio (Nasdaq: CABA) is a clinical-stage biotechnology company focused on developing and launching targeted, potentially curative, cellular therapies for patients with autoimmune diseases. The CABA™ platform includes two strategies to treat and potentially cure many of the most common and challenging autoimmune diseases. The CARTA strategy, or Chimeric Antigen Receptor T cells for Autoimmunity, is designed to potentially reset the immune system by causing transient B cell depletion with early academic clinical data suggesting the potential of this strategy to transform treatment in patients with SLE and the possibility of cures in rheumatoid arthritis, myositis, and systemic sclerosis, among others. Our lead product candidate using the CARTA strategy is CABA-201, 4-1BB-containing CD19-CAR T designed specifically to treat patients with autoimmune diseases, including SLE/lupus nephritis and myositis and which uses a CD-19 binder that has an encouraging clinical tolerability profile. The second strategy is Cabaletta Bio’s proprietary CAART, or chimeric autoantibody receptor T cells, strategy, which is designed to cause antigen-specific B cell depletion of well-defined, disease-causing B cells. Our lead product candidate developed using the CAART strategy is being evaluated in a clinical trial for patients with mucosal pemphigus vulgaris (mPV) and our second product candidate is expected to initiate a clinical trial later this year in muscle-specific tyrosine kinase (MuSK) myasthenia gravis. Cabaletta Bio’s headquarters are located in Philadelphia, PA. For more information, visit www.cabalettabio.com and follow us on LinkedIn and Twitter.

 

Uniquely Differentiated. Rapid. Elegant.

At Cabaletta, we are driven by the shared mission of developing cures, where a patients’ own cells are used to fight disease. We are building a culture grounded in the knowledge that successful cures can be achieved for patients if every member of the Cabaletta is focused on the success of the team. To nurture this, we make an active commitment to the well-being and continuous growth of each employee who joins the team. In this way, we are not only working to improve the lives of patients, but of everyone involved. #CabalettaCrew. 

We’re proud to be a Great Place to Work-Certified™ company! #GPTWcertified Check out what our employees say makes working here so great:  Working at Cabaletta Bio Inc | Great Place to Work®

 

About the Position

 

 

Reporting to the Senior Scientist, Preclinical Research, we are seeking an experienced, motivated, detail-oriented, and highly skilled Associate Scientist to join our preclinical research team. Under scientific and technical supervision, the individual will perform various cell-based assays and other in vitro and ex vivo based assays to contribute to the discovery and development of novel therapeutics at Cabaletta. Additionally, the individual will be responsible for cell line generation and maintenance to assist in the development of novel cell-based assays for the Cellular Immunology team. The position allows for potential impact in additional areas within Cabaletta, including translational research and molecular biology, immunology, and cell therapy development.

Responsibilities:

• Maintain accurate and well-organized records and electronic laboratory notebook.
• Perform lab associated tasks in accordance with cGLP and Cabaletta Bio lab safety policies and SOPs.
• Actively contribute to process improvements and the implementation of new technologies.
• Manage multiple internal projects for Translational, Analytical, and Manufacturing Sciences, as well as involvement in collaborations with external vendors.
• Maintain and expand, bank, and manage various cell lines.
• Cell line generation using lentivirus technology for suspension cell lines.
• Perform cytotoxicity and flow cytometry assays.

 

Qualifications:

 

• MS degree in Biology or Bioengineering (or related field) with 2 + years of experience, or bachelor’s degree with 4+ years of experience in the biotechnology industry required. Ph.D. level candidates will be considered as well.
• General lab skills, including aseptic techniques and human tissue handling required.
• Prior experience with mammalian cell culture (aseptic techniques)
• Significant lab experience and expertise in cell husbandry required, including maintaining cell culture, media preparation, generating and managing cell stocks and banking.
• Experience in primary cell and iPSC derived cell culture preferred.
• Must be highly organized and able to work independently.
• Must be able to clearly communicate in writing, must have a desire to be part of a growing organization that uses cutting-edge science.
• A high level of flexibility to support various other activities the ability to learn new techniques outside of existing field of expertise.
• Strong team orientation and passion for continuous self-development
• Experience in industry or in startup industrial setting is preferred.

Our name – Cabaletta – is derived from the operatic term that represents a rapid, repetitive, and technically challenging section of an operatic aria, designed to showcase the skills of the lead singer. Analogously, Cabaletta Bio strives to achieve rapid and repetitive product development, building on our indication prioritization and biologic platform that targets the driver of specific autoimmune diseases without the need for long-term immunosuppression.

 For more information, please visit  https://www.cabalettabio.com/join-our-crew

 Our most important asset is our people, and we offer competitive benefits, PTO, and stock option plans.

Cabaletta Bio is an equal opportunity employer. We do not discriminate on the basis of race, color, gender, gender identity, sexual orientation, age, religion, national or ethnic origin, disability, protected veteran status or any other basis protected by applicable law.

 Cabaletta Bio, Inc. does not accept unsolicited resumes from recruiters, employment agencies, or staffing firms. To conduct business with Cabaletta, a Master Services Agreement (MSA) must be executed and confirmed prior to submitting any information relating to a potential candidate. Without a signed MSA, Cabaletta shall not be responsible to any individual or entity for any payment relating to any form of fee or compensation.

 

 And, if a resume or candidate is submitted by a recruiter, an employment agency, or a staffing firm without a fully executed MSA, Cabaletta has the unrestricted right to pursue and hire any of those candidate(s) without any legal or financial responsibility to the recruiter, agency, and/or firm.